Analysis of the metabolism of haloperidol and its neurotoxic pyridinium metabolite in patients with drug-induced parkinsonism

Neuropsychobiology

Volumn 44, Issue 3, 2001, Pages 126-128

  Iwahashi, K ^a   Anemo, K ^b   Nakamura, K ^b   Fukunishi, I ^c   Igarashi, K ^d  

^a AZABU UNIVERSITY   (Japan)

^b KAGAWA PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

Haloperidol; HPP; Vitamin E

Indexed keywords

4 (4 CHLOROPHENYL) 1 [4 (4 FLUOROPHENYL) 4 OXOBUTYL]PYRIDINIUM; ALPHA TOCOPHEROL; CARBAMAZEPINE; DRUG METABOLITE; HALOPERIDOL; PYRIDINIUM DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG METABOLISM; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NEUROPROTECTION; NEUROTOXICITY; PARKINSONISM; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; SCORING SYSTEM; STUDENT T TEST;

ADULT; ANTIPSYCHOTIC AGENTS; CHROMATOGRAPHY, LIQUID; FEMALE; HALOPERIDOL; HUMANS; PARKINSONIAN DISORDERS; PYRIDINIUM COMPOUNDS; SCHIZOPHRENIA; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 0035741972     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054931     Document Type: Article

References (18)

1. Drugs and the treatment of psychiatric disorders
2. Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: Phenomenology, pathophysiology and putative relationship to tardive dyskinesia
3. The possible role of an active metabolite derived from the neuroleptic agent haloperidol in drug-induced parkinsonism
4. Analysis of haloperidol and its neurotoxic pyridinium metabolite in biological samples by liquid chromatography/mass spectrometry
5. The pharmacology of the parkinsonian syndrome producing neuro-toxin MPTP (1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine) and structurally related compounds
6. Mechanism underlying neuronal degeneration in Parkinson's disease: An experimental and theoretical treatise
7. Significantly higher plasma haloperidol level during cotreatment with carbamazepine may herald cardiac change
8. Involvement of CYP3A4 and CYP2D6 in the metabolism of haloperidol
9. Effect of carbamazepine on plasma haloperidol levels
10. Effect of carbamazepine on serum antide-pressant concentrations in psychiatric patients
11. Metabolic interaction between imipramine and carbamazepine in vivo and in vitro
12. Homologous unequal cross-over involving a 2.8 kb direct repeat as a mechanism for the generation of allelic variants of human cytochrome P450 CYP2D6 gene
13. Genetic analysis of the Chinese cytochrome P4502D locus: Characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation
14. In vitro study on the involvement of CYP1A2, CYP2D6 and CYP3A4 in the metabolism of haloperidol and reduced haloperidol
15. Formation of pyridinium species of haloperidol in human liver and brain
16. Effects of itraconazole on the steady-state plasma concentrations of bromperidol and reduced bromperidol in schizophrenic patients
17. Vitamin E in the treatment of tardive dyskinesia
18. Managing antipsychotic-induced tardive dyskinesia